...
首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Evaluation of T cell stimulation by thyrotropin-receptor epitopes in Graves' disease.
【24h】

Evaluation of T cell stimulation by thyrotropin-receptor epitopes in Graves' disease.

机译:促甲状腺激素受体表位对Graves病患者T细胞刺激的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

In Graves' disease (GD) immunized T cells reactive to TSH-receptor epitopes contribute to pathogenesis through B cell help, and cytotoxicity. We evaluated T cell responses to synthetic TSH-receptor epitopes in hyperthyroid patients with GD prior to therapy, at 6-8 weeks after radioactive iodine (RAI) administration, or 6-8 months later when euthyroid, and in control subjects. All T cell responses were relatively low as generally found in human autoimmune diseases. Responses in hyperthyroid GD patients were significantly greater than among controls, were augmented 6-8 weeks after RAI treatment, were still present after patients became euthyroid, and did not differ between DR3+ and non-DR3+ patients. Patient's T cells reacted to multiple different epitopes, and reactivity differed depending on the course of the disease and treatment.While certain epitopes most commonly cause T cell reactivity, we did not find evidence for a single or few "dominant" epitopes.
机译:在Graves病(GD)中,对TSH受体表位具有反应性的免疫T细胞通过B细胞帮助和细胞毒性促进发病机理。我们在治疗前,放射性碘(RAI)给药后6-8周或甲状腺功能正常后6-8个月评估了甲状腺功能亢进的GD患者的T细胞对合成TSH受体表位的反应。正如人类自身免疫性疾病中普遍发现的那样,所有T细胞反应都相对较低。甲状腺功能亢进的GD患者的反应显着高于对照组,在RAI治疗后6-8周增强,在患者变为甲状腺功能正常后仍然存在,并且DR3 +和非DR3 +患者之间无差异。患者的T细胞对多种不同的表位有反应,反应性因疾病和治疗的过程而异。尽管某些表位最常引起T细胞反应性,但我们没有发现单个或少数“显性”表位的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号